3 resultados
Resultados de la búsqueda
Mostrando 1 - 3 de 3
Ítem Autoimmune/Inflammatory Syndrome Induced by Adjuvants Causing Myositis and Pulmonary Fibrosis(Israel Medical Association, 2013-11-01) García, José F.Anaphylaxis is defined as a serious, rapid onset, systemic allergic reaction that may cause death.1-5 The diagnosis is based primarily on clinical history, and clinical criteria for accurate and early identification of anaphylaxis have recently been established.1 The lifetime prevalence of anaphylaxis from all triggers is estimated to range from 0.05% to 2.6%. Data on anaphylaxis Anaphylaxis online survey in Latin America Sole´ D et al.Ítem Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy(Springer-Verlag London Ltd, 2014-03-01) Betancurt, J. F.New cases of Pneumocystis jirovecii pneumonia (PJP) have recently been reported in patients with systemic lupus erythematosus (SLE) after rituximab therapy. Several factors may contribute to susceptibility to P. jirovecii infection in this type of patients, including the immunological characteristics of the disease, the mechanisms of rituximab action, environmental factors, and the biological characteristics of the fungus. We report two patients with SLE who developed PJP after rituximab therapy.Ítem Curso clínico de pacientes de trasplante autógeno de médula ósea portadores del virus linfotrópico humano(Elsevier Doyma, 2015-07-01) Vélez, Juan DiegoHuman T-lymphotropic virus 1 infection is common in Colombia's Pacific coast and has been linked to adult T-cell leukemia/lymphoma and human T-lymphotropic virus 1-associated myelopathy in a low percentage of cases. In patients with solid organ transplantation, these diseases occur more quickly than in other scenarios but in bone marrow transplantation the true impact is unknown. We describe 3 seropositive patients with lymphoma who underwent autologous stem cell transplantation; in one case there was relapse of the hematologic malignancy and death occurred as a result. Another patient had symptoms compatible with human T-lymphotropic virus 1-associated myelopathy and the last patient had a graft vs. host disease. In seropositive people who need hematopoietic cell transplantation, an active search for this virus is required to be able to follow and assess the virus's impact on outcomes, as well as to assess whether the evolution could change according to the transplant conditioning regimen.